Author | Suresh A. Ramalingam, MD | OncLive

Author | Suresh A. Ramalingam, MD


Dr. Ramalingam on Next Steps With Nivolumab/Ipilimumab in NSCLC

July 24, 2020


Suresh S. Ramalingam, MD, FASCO, discusses the utility of nivolumab plus ipilimumab in metastatic or recurrent non–small cell lung cancer.

Dr. Ramalingam on Pembrolizumab and Chemotherapy in NSCLC

February 27, 2018


Suresh A. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, discusses data with pembrolizumab (Keytruda) and chemotherapy in patients with non–small cell lung cancer (NSCLC).